Drug · DIN 02234470
ATGAM
ALSO KNOWN AS LYMPHOCYTE IMMUNE GLOBULIN ANTI-THYMOCYTE GLOBULIN (EQUINE)
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since August 23, 2006; first marketed December 4, 1998.
- Drug Identification Number (DIN)
- 02234470
- Company (DIN owner)
- Pfizer Canada UlcKirkland, Quebec, Canada
- Schedule
- Prescription; Schedule D
- Dosage form
- Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Antilymphocyte immunoglobulin (horse) L04AA03
- Class
- Human
- Record last updated
- September 17, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| LYMPHOCYTE IMMUNOGLOBULIN ANTI-THYMOCYTE GLOBULIN (EQUINE) | 50 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 18, 2003: NOC 1559New Drug Submission (NDS) · Manufacturer name change
- July 18, 2001: NOC 2372New Drug Submission (NDS) · Manufacturer name change
- September 22, 1997: NOC 3920Supplement to a New Drug Submission (SNDS) · Change in formulation